Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.36K Sell
7,932
-47,599
-86% -$39K ﹤0.01% 4765
2025
Q4
$50.5K Buy
55,531
+11,154
+25% +$10.7K ﹤0.01% 4740
2025
Q3
$39.6K Sell
44,377
-13,221
-23% -$19.2K ﹤0.01% 4821
2025
Q2
$124K Buy
57,598
+57,277
+17,843% +$208K ﹤0.01% 4513
2025
Q1
$1.54K Sell
321
-7,025
-96% -$40K ﹤0.01% 5015
2024
Q4
$47.3K Sell
7,346
-1,612
-18% -$7.84K ﹤0.01% 4774
2024
Q3
$35.9K Buy
+8,958
New +$37.1K ﹤0.01% 4811
2020
Q1
Sell
-2
Closed 6352
2019
Q4
$0 Buy
+2
New +$32 ﹤0.01% 6646

Other funds holding MYO

Barclays's MYO Position: Q1 2026 in Review

Barclays reduced its Myomo (MYO) stake by 86% in Q1 2026, selling an estimated $39K and leaving 7,932 shares worth $5.36K. The position accounts for ﹤0.01% of the portfolio, ranked #4765.

Barclays first reported a position in MYO in Q4 2019 and has held it in 8 quarters since. The position peaked at $124K in Q2 2025. 80 funds tracked by Wall St. Rank hold MYO as of Q1 2026.

  • Barclays held 7,932 shares of Myomo worth $5.36K as of Q1 2026.
  • Barclays sold 47,599 Myomo shares in Q1 2026, an estimated $39K.
  • Myomo made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4765 holding.
  • Barclays first reported a position in Myomo in Q4 2019 and has held it in 8 quarters since.
  • Barclays's Myomo position peaked at $124K in Q2 2025.
  • 80 funds tracked by Wall St. Rank held Myomo as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.